Log in to save to my catalogue

Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone

Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10878974

Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone

About this item

Full title

Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2024-02, Vol.30 (2), p.394-402

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Alzheimer’s disease (AD) is characterized pathologically by amyloid-beta (Aβ) deposition in brain parenchyma and blood vessels (as cerebral amyloid angiopathy (CAA)) and by neurofibrillary tangles of hyperphosphorylated tau. Compelling genetic and biomarker evidence supports Aβ as the root cause of AD. We previously reported human transmission of A...

Alternative Titles

Full title

Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10878974

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10878974

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-023-02729-2

How to access this item